Purpose-built for pharmaceutical companies
Social listening strengthens pharmacovigilance by enabling continuous surveillance of public conversations about drug experiences. It provides early visibility into safety concerns, allowing pharma companies to act faster and prevent harm.
Identify patterns and potential adverse events as they emerge in real time.
Monitor across diverse digital platforms, patient communities, and geographic regions.
Support regulatory compliance by streamlining data collection and improving reporting timelines.
Define the scope of drugs, terms, and adverse reactions to monitor.
Use AI-driven tools to detect patterns and signal clusters quickly.
Feed findings directly into safety management systems for evaluation and response.
Gain real-time visibility into emerging drug risks for quicker intervention.
Continuously monitor safety performance across all markets and patient groups.
Strengthen stakeholder trust by maintaining high standards of transparency and safety vigilance.